Two Sigma Investments, LP Xencor Inc Transaction History

Two Sigma Investments, LP

$59 Billion
Q3 2025

A detailed history of Two Sigma Investments, LP transactions in Xencor Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 629,376 shares of XNCR stock, worth $9.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

629,376

Previous 439,843 43.09%

Holding current value

$9.4 Million

Previous $3.46 Million 113.54%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$7.0 - $11.73 $1.33 Million - $2.22 Million	189,533 Added 43.09%	629,376 $7.38 Million
Q2 2025 Aug 14, 2025	BUY	$7.52 - $11.26 $1.01 Million - $1.52 Million	134,712 Added 44.15%	439,843 $3.46 Million
Q1 2025 May 15, 2025	BUY	$10.64 - $24.13 $84,141 - $190,820	7,908 Added 2.66%	305,131 $3.25 Million
Q4 2024 Feb 14, 2025	SELL	$19.43 - $26.84 $3.35 Million - $4.63 Million	-172,614 Reduced 36.74%	297,223 $6.83 Million
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $498,898 - $687,972	-31,777 Reduced 6.33%	469,837 $9.45 Million

Q2 2024 Aug 14, 2024	SELL	$18.21 - $24.5 $1.78 Million - $2.4 Million	-97,899 Reduced 16.33%	501,614 $9.5 Million
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $3.8 Million - $5.4 Million	203,786 Added 51.5%	599,513 $13.3 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $2.81 Million - $3.64 Million	170,051 Added 75.35%	395,727 $8.4 Million
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $278,810 - $352,540	13,885 Added 6.56%	225,676 $4.55 Million
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $513,432 - $619,767	20,728 Added 10.85%	211,791 $5.29 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $1.5 Million - $2.14 Million	57,944 Added 43.53%	191,063 $5.33 Million
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $1.11 Million - $1.39 Million	44,881 Added 50.86%	133,119 $3.47 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $886,787 - $1.17 Million	36,019 Added 68.98%	88,238 $2.29 Million
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $910,566 - $1.34 Million	-46,128 Reduced 46.9%	52,219 $1.43 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $2.62 Million - $4.09 Million	98,347 New	98,347 $2.62 Million
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $649,136 - $755,666	-21,179 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $727,315 - $946,590	-21,186 Reduced 50.01%	21,179 $730,000
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $1.73 Million - $2.28 Million	42,365 New	42,365 $1.82 Million
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $967,483 - $1.38 Million	-32,153 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $892,567 - $1.07 Million	32,153 New	32,153 $1.04 Million
Q3 2018 Nov 14, 2018	SELL	$35.69 - $47.65 $6.85 Million - $9.15 Million	-191,932 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$28.41 - $42.41 $7.46 Million - $11.1 Million	-262,741 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$21.18 - $33.78 $4.18 Million - $6.67 Million	197,323 Added 301.63%	262,741 $7.88 Million
Q4 2017 Feb 14, 2018	BUY	$19.29 - $24.83 $1.26 Million - $1.62 Million	65,418	65,418 $1.43 Million

Others Institutions Holding XNCR

# of Institutions

220

Shares Held

81.4M

Call Options Held

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $891M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Xencor Inc Transaction History